Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT38 in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
NCT03613129Phase 2Completed
- Start
- Jul 2018
- Primary completion
- Apr 2019
- Countries
- 1
01
Overview
A Phase 2 trial of CT38 in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Started Jul 2018; status: completed.
02
Drugs
CT38
03
Conditions
myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Beyond the preview
Go deeper on NCT03613129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03613129.